Completed
ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab
NCT02296424
- Conditions
- Arthralgia, Arthritis, Arthritis, Juvenile, +23 more
- Locations
-
- Novartis Investigative Site Los Angeles, California, United States
- Novartis Investigative Site Columbus, Ohio, United States
- Novartis Investigative Site Vienna, Austria
- Novartis Investigative Site Brussels, Belgium